Jane Talvenheimo
Overview
Explore the profile of Jane Talvenheimo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polverino A, Coxon A, Starnes C, Diaz Z, DeMelfi T, Wang L, et al.
Cancer Res
. 2006 Sep;
66(17):8715-21.
PMID: 16951187
The growth of solid tumors is dependent on the continued stimulation of endothelial cell proliferation and migration resulting in angiogenesis. The angiogenic process is controlled by a variety of factors...
2.
Klionsky L, Tamir R, Holzinger B, Bi X, Talvenheimo J, Kim H, et al.
J Pharmacol Exp Ther
. 2006 Jul;
319(1):192-8.
PMID: 16844842
Transient receptor potential vanilloid type 1 (TRPV1) can be activated by multiple chemical and physical stimuli such as capsaicin, anandamide, protons, and heat. Capsaicin interacts with the binding pocket constituted...
3.
Wei P, Zhan J, Liu S, Chang D, Haldankar R, Burkhardt K, et al.
Hybridoma (Larchmt)
. 2006 Jun;
25(3):115-24.
PMID: 16796457
Keratinocyte growth factor receptor (KGFR) and fibroblast growth factor receptor (FGFR) 2c share identical amino acid sequences, except for a 46-amino acid domain in the extracellular region. Monoclonal antibodies (MAbs)...
4.
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties
Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T, et al.
Clin Cancer Res
. 2003 Sep;
9(10 Pt 2):3982S-90S.
PMID: 14506197
Purpose: Epratuzumab is a novel humanized antihuman CD22 IgG1 antibody that has recently shown promising clinical activity, both as a single agent and in combination with rituximab, in patients with...
5.
Sun B, Fan W, Balciunas A, Cooper J, Bitan G, Steavenson S, et al.
Neurobiol Dis
. 2002 Dec;
11(1):111-22.
PMID: 12460551
Amino-terminal fragments of huntingtin, which contain the expanded polyglutamine repeat, have been proposed to contribute to the pathology of Huntington's disease (HD). Data supporting this claim have been generated from...
6.
Li T, Talvenheimo J, Zeni L, Rosenfeld R, Stearns G, Arakawa T
Biopolymers
. 2002 Feb;
67(1):10-9.
PMID: 11842409
The interactions of brain-derived neurotrophic factor (BDNF) with the extracellular domain of its receptor (trkB) are investigated by employing isotope-edited Fourier transform IR (FTIR) spectroscopy. The protein secondary structures of...